HBW Insight editors discuss the latest European consumer healthcare industry news. This week, Tom Gallen and David Ridley examine how a growing number of EU member states are allowing prebiotic and probiotic on food supplement labels, despite EFSA regulations; a last minute revision of the UK's CBD regulations, which allow products linked to a novel food application - not necessarily validated - to remain on the market from the end of this month, as well as a group of companies that have all received a pre-validation from the FSA thanks to a consortium-based approach; and finally how GSK is exploring sustainable paper bottles for three of its biggest consumer health brands to advance its ambitious sustainability strategy.